---
title: "AI and Batteries: Last Hope for Hong Kong's Forgotten Stocks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302534770.md"
description: "Niche Hong Kong stocks are pivoting to AI and energy storage amid revenue declines. Greenleaf Pharma's CNS focus and Wasion's $170M Middle East deal show strategic shifts, while Tigerdom and Yihuo face structural challenges. CRCC's stealth energy move highlights sector-wide reinvention attempts."
datetime: "2026-10-21T09:16:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302534770.md)
  - [en](https://longbridge.com/en/news/302534770.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302534770.md)
generator: "portal-rs"
---

# AI and Batteries: Last Hope for Hong Kong's Forgotten Stocks

Hong Kong's forgotten small-caps are scrambling for relevance as traditional revenue streams dry up. Greenleaf Pharma (2186.HK) pivoted hard to CNS drugs, betting on its newly approved ERZOFRI® and September's AI-powered drug delivery partnership with METIS TECHBIO to escape the 'second BeiGene' narrative. Meanwhile, Wasion Holdings (3393.HK) landed a $170M Middle East smart grid contract and cleared U.S. ANSI certification—rare wins for a stock drowning in sector-wide skepticism.

Contrast this with Tigerdom (2399.HK), where declining apparel revenue now dominates 79% of a shrinking business, or Yihuo International (8659.HK) struggling with 42% year-on-year plastic container sales drops. Yet even industrial strugglers see glimmers: CRCC (1186.HK) quietly launched Guangzhou Zhichu Energy Storage, while Guoxia Tech (2655.HK) drew 'buy' ratings despite 15% recent pullbacks. The real story? These stocks aren't waiting for market sentiment—they're rewriting their playbooks in real time.

### Related Stocks

- [02186.HK](https://longbridge.com/en/quote/02186.HK.md)
- [03393.HK](https://longbridge.com/en/quote/03393.HK.md)
- [02399.HK](https://longbridge.com/en/quote/02399.HK.md)
- [00347.HK](https://longbridge.com/en/quote/00347.HK.md)
- [00475.HK](https://longbridge.com/en/quote/00475.HK.md)
- [02655.HK](https://longbridge.com/en/quote/02655.HK.md)
- [01186.HK](https://longbridge.com/en/quote/01186.HK.md)
- [00550.HK](https://longbridge.com/en/quote/00550.HK.md)
- [09600.HK](https://longbridge.com/en/quote/09600.HK.md)
- [08659.HK](https://longbridge.com/en/quote/08659.HK.md)

## Related News & Research

- [Wasion Holdings Reports Share Buyback in HKEX Next Day Disclosure Return](https://longbridge.com/en/news/306242052.md)
- [Wasion Holdings Files HKEX Next-Day Disclosure Return Announcing Share Buyback](https://longbridge.com/en/news/306086881.md)
- [Luye Pharma's Ruoxinlin Wins China Approval for Generalized Anxiety Disorder](https://longbridge.com/en/news/306110668.md)
- [Wasion Holdings Files HKEX Next-Day Disclosure Return Announcing Share Buyback](https://longbridge.com/en/news/305639667.md)
- [Luye Pharma’s Ruoxinlin Renewed in China’s 2026 Reimbursement Drug List](https://longbridge.com/en/news/305580065.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**